Beyond the Biotek 47 podcast

The Daiichi-Sankyo company and AstraZeneca have been working together for several years.

This week’s podcast is sponsored by Daiichi Sankyo And AstraZeneca.

On this week’s podcast, we speak with Markus Kosch, head of Oncology Europe for Daiichi-Sankyo, and Greg Rossi, Senior Vice President, Oncology, Europe and Canada, from AstraZeneca, who are joining forces to bring new oncology drugs into clinical practice.

In March 2019, AstraZeneca and Daiichi-Sankyo entered into a global partnership to jointly develop and commercialize healthcare technology around the world. Their collaboration is designed to leverage strengths and combine efforts to improve patient care.